DSM-Firmenich AG (FRA:ZX6) FFO


FRA:ZX6 DSM-Firmenich AG FRA:ZX6
51 GF Score
Price €79.98
GF Value €75.94
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG FFO?

FFO (Funds from operations) only applies to REITs.

FRA:ZX6
51GF Score
DSM-Firmenich AG FRA:ZX6
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (FRA:ZX6) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €79.98 is trading 5.3% above its estimated GF Value™ of €75.94. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for FRA:ZX6:

  • FFO:
  • GF Value™: €75.94 vs. price of €79.98 (5.3% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the FRA:ZX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
51GF Score

Get the complete analysis for FRA:ZX6

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.98
Price
€75.94
GF Value